These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 10717092)
1. Early Reactions as Dose-Limiting Factors in Radiotherapy. Kaanders JH; Ang KK Semin Radiat Oncol; 1994 Apr; 4(2):55-67. PubMed ID: 10717092 [TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions. Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401 [TBL] [Abstract][Full Text] [Related]
4. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer. Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514 [TBL] [Abstract][Full Text] [Related]
5. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
7. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes. López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114 [TBL] [Abstract][Full Text] [Related]
8. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice]. Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442 [TBL] [Abstract][Full Text] [Related]
9. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy. Marcu LG Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726 [TBL] [Abstract][Full Text] [Related]
10. Altered fractionation: limited by mucosal reactions? Kaanders JH; van der Kogel AJ; Ang KK Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810 [TBL] [Abstract][Full Text] [Related]
11. Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework. Porock D Eur J Cancer Care (Engl); 2002 Mar; 11(1):33-43. PubMed ID: 11966833 [TBL] [Abstract][Full Text] [Related]
12. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475 [TBL] [Abstract][Full Text] [Related]
13. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system. Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148 [TBL] [Abstract][Full Text] [Related]
14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
15. Head and neck squamous cell carcinoma: optimizing the therapeutic index. Rosenthal DI; Blanco AI Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957 [TBL] [Abstract][Full Text] [Related]
16. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. Allal AS; Taussky D; Mach N; Becker M; Bieri S; Dulguerov P Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1431-6. PubMed ID: 15050320 [TBL] [Abstract][Full Text] [Related]
17. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients. Siegel JA; Yeldell D; Goldenberg DM; Stabin MG; Sparks RB; Sharkey RM; Brenner A; Blumenthal RD J Nucl Med; 2003 Jan; 44(1):67-76. PubMed ID: 12515878 [TBL] [Abstract][Full Text] [Related]
18. New treatment modalities in radiation therapy. Holland J J Intraven Nurs; 2001; 24(2):95-101. PubMed ID: 11836839 [TBL] [Abstract][Full Text] [Related]
19. Genetic variation in normal tissue toxicity induced by ionizing radiation. Popanda O; Marquardt JU; Chang-Claude J; Schmezer P Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265 [TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]